Webinar 31 de octubre 2019 Microheterogeneities are inherent features of monoclonal antibodies (mAbs) due to their susceptibility to chemical and enzymatic modifications. These heterogeneities impact both biotherapeutic efficacy and safety, and accordingly are a critical quality criterion.
Más información
